Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Cancer de la vessie/uretère

  • Chapter
Thérapeutique du cancer

  • 765 Accesses

Résumé

Les tumeurs urothéliales sont des tumeurs fréquentes qui se développent aux dépens de l’arbre urinaire. Elles siègent le plus souvent dans la vessie mais elles peuvent aussi avoir comme origine le haut appareil urinaire (uretères et bassinet rénal) ou l’urètre. Leur prise en charge repose sur une collaboration médico-chirurgicale.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Ferlay J, Randi G, Bosetti C et al. (2008) Declining mortality from bladder cancer in Europe. BJU Int 101: 11–19

    PubMed  Google Scholar 

  2. Belot A, Grosclaude P, Bossard N et al. (2008) Cancer incidence and mortality in France over the period 1980–2005. Rev Epidemiol Sante Publique 56: 159–175

    Article  PubMed  CAS  Google Scholar 

  3. Kirkali Z, Chan T, Manoharan M et al. (2005) Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66(6 Suppl 1): 4–34

    Article  PubMed  Google Scholar 

  4. Eble J, Sauter G, Epstein J, Sesterhenn I (2004) Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press

    Google Scholar 

  5. Gilligan T, Steele G, Zietman A, Kantoff P (2006) Bladder cancer. In: Holland JF, Frei E, editors. Cancer Medicine. 7 ed. Hamilton, London: BC Decker Inc 1415–1430

    Google Scholar 

  6. Lamm DL, Blumenstein BA, Crissman JD et al. (2000) Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163: 1124–1129

    Article  PubMed  CAS  Google Scholar 

  7. Stein JP, Lieskovsky G, Cote R et al. (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19: 666–675

    PubMed  CAS  Google Scholar 

  8. Grossman HB, Natale RB, Tangen CM et al. (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349: 859–866

    Article  PubMed  CAS  Google Scholar 

  9. (2005) Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48: 202–205

    Google Scholar 

  10. Lehmann J, Franzaring L, Thuroff J et al. (2006) Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer. BJU Int 97: 42–47

    Article  PubMed  Google Scholar 

  11. (2005) Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 48: 189–199

    Google Scholar 

  12. Saxman SB, Propert KJ, Einhorn LH et al. (1997) Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol 15: 2564–2569

    PubMed  CAS  Google Scholar 

  13. von der Maase MH, Sengelov L, Roberts JT et al. (2005) Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 23: 4602–4608

    Article  PubMed  Google Scholar 

  14. Sternberg CN, de M P, Schornagel JH et al. (2006) Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and GCSF versus classic M-VAC in advanced urothelial tract tumours. Eur J Cancer 42: 50–54

    Article  PubMed  CAS  Google Scholar 

  15. Milosevic M, Gospodarowicz M, Zietman A et al. (2007) Radiotherapy for bladder cancer. Urology 69(1 Suppl): 80–92

    Article  PubMed  Google Scholar 

  16. Babjuk M, Oosterlinck W, Sylvester R et al. (2008) EAU guidelines on nonmuscle-invasive urothelial carcinoma of the bladder. Eur Urol 54: 303–314

    Article  PubMed  Google Scholar 

  17. Stenzl A, Cowan NC, De SM et al. (2009) The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer. Eur Urol

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département de cancérologie médicale, Centre Léon-Bérard, 28 rue Laënnec, 69008, Lyon

    H. Boyle, A. Fléchon & J.-P. Droz

Authors
  1. H. Boyle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Fléchon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J.-P. Droz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France

About this chapter

Cite this chapter

Boyle, H., Fléchon, A., Droz, JP. (2011). Cancer de la vessie/uretère. In: Thérapeutique du cancer. Springer, Paris. https://doi.org/10.1007/978-2-8178-0021-9_30

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0021-9_30

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0020-2

  • Online ISBN: 978-2-8178-0021-9

Publish with us

Policies and ethics

Search

Navigation